NEW YORK ( TheStreet) -- We hear all the time that when (fill in the blank) speaks, people listen.It is clear TheStreet's Jim Cramer fits into that category. After seeing the 33% surge in shares of TearLab> ( TEAR) only a few days after Cramer discussed the company's prospects on national television, I realize I need to listen to him more intently. While the med-tech space is not exactly new to me, for several reasons TearLab had fallen off my radar. But after Cramer's comments and the stock's immediate jump, the company's got my attention. Investors want to know if it's too late to profit. Take a look at the chart below.